TissueTech fleshes out $10M equity round

August 22, 2013 by Brad Perriello

TissueTech says it's raised $10 million in equity financing for its regenerative medicine technology.

TissueTech fleshes out $10M equity round

TissueTech Inc. said it pulled down $10 million from a pair of venture capital shops to back its regenerative medicine subsidiaries, Bio-Tissue and Amniox Medical.

The equity round came from Ballast Point Ventures and River Cities Capital Funds, according to a press release.

Doral, Fla.-based TissueTech makes amniotic membrane- and umbilical cord-based products designed to treat ocular surface diseases (Bio-Tissue) and musculoskeletal conditions and wound care (Amniox Medical), according to the release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.